Showing results (231-240 of 282) with videos related to

Sort By:
Pageof 29
Cancer Detection and Prevention|January 1, 1989
Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patientsG Mantovani, F G Serri, A Macciò, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 12, 2007
Bulky lymph node resection in patients with recurrent epithelial ovarian cancer: impact of surgeryP Benedetti Panici, G Perniola, R Angioli, et al.
Anticancer Research|November 1, 1989
Epidermal growth factor levels in human breast cyst fluidF Battaglia, S Rossi, G Scambia, et al.
Bone Marrow Transplantation|December 1, 1994
Low-dose cyclophosphamide in combination with cisplatin or epirubicin plus rhG-CSF allows adequate collection of PBSC for autotransplantation during adjuvant therapy for high-risk cancerG Menichella, L Pierelli, G Scambia, et al.
Gynecologic Oncology|April 1, 1996
Locally advanced cervical adenocarcinoma: is there a place for chemo-surgical treatment?P Benedetti-Panici, S Greggi, G Scambia, et al.
British Journal of Haematology|December 1, 1991
Antiproliferative activity of quercetin on normal bone marrow and leukaemic progenitorsL M Larocca, L Teofili, G Leone, et al.
British Journal of Cancer|October 1, 1996
Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinomaM Maurizi, G Almadori, G Ferrandina, et al.
International Journal of Cancer|December 2, 1992
EGF receptor expression in primary laryngeal cancer: correlation with clinico-pathological features and prognostic significanceM Maurizi, G Scambia, P Benedetti Panici, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1994
Squamous cell carcinoma antigen: prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancerG Scambia, P Benedetti Panici, E Foti, et al.
Haematologica|March 1, 1991
High dose chemotherapy with cisplatin, VP16 and carboplatin with stem cell support in patients with advanced ovarian cancerL Pierelli, G Menichella, M L Foddai, et al.
Pageof 29